Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Toagosei America is the North American subsidiary of Toagosei Co., Ltd., a prominent Japanese chemical manufacturer. The company is globally recognized for its Aron Alpha brand of cyanoacrylate adhesives, which includes specialized formulations for medical use in wound closure and surgical procedures. In addition to its adhesive business, Toagosei is active in the life sciences through the development of proprietary cell-penetrating peptide (CPP) technology designed to enhance the intracellular delivery of therapeutic agents. The company also produces a wide range of specialty chemicals, including UV-curable resins and high-purity acrylic polymers. Headquartered in Ohio, Toagosei America serves as a key hub for manufacturing, R&D, and distribution within the Americas.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Toagosei America.